You are here

Home

Clinical Trials: Digestive System Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Monday, September 14, 2020 - 12:00
Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Crohn's Colitis
Condition:   Crohn Colitis
Interventions:   Drug: remesetemcel-L;   Other: Placebo
Sponsors:   The Cleveland Clinic;   Mesoblast, Inc.
Not yet recruiting
Posted: Thursday, September 10, 2020 - 12:00
Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Ulcerative Colitis (UC)
Condition:   Ulcerative Colitis
Interventions:   Drug: Remestemcel-L;   Other: Placebo
Sponsors:   The Cleveland Clinic;   Mesoblast, Inc.
Not yet recruiting
Posted: Thursday, August 20, 2020 - 12:00
Mesenchymal Stem Cells for the Treatment of Rectovaginal Fistulas in Participants With Crohn's Disease
Conditions:   Rectovaginal Fistula;   Crohn Disease;   Crohn Disease of Vulva;   Rectolabial; Fistula
Interventions:   Drug: Mesenchymal Stem Cells;   Other: Placebo
Sponsor:   The Cleveland Clinic
Not yet recruiting
Posted: Thursday, August 20, 2020 - 12:00
Study of Mesenchymal Stem Cells for the Treatment of Ileal Pouch Fistula's in Participants With Crohn's Disease
Conditions:   Ileal Pouch;   Crohn Disease
Interventions:   Drug: Mesenchymal stem cells;   Other: Placebo
Sponsor:   The Cleveland Clinic
Not yet recruiting
Posted: Thursday, August 20, 2020 - 12:00
Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease
Conditions:   Perianal Crohn Disease;   Perianal Fistula;   Crohn Disease
Interventions:   Drug: Mesenchymal Stem Cells;   Other: Placebo
Sponsor:   The Cleveland Clinic
Not yet recruiting
Posted: Wednesday, April 22, 2020 - 12:00
Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B
Condition:   Liver Cirrhoses
Intervention:   Biological: Allogeneic Umbilical Cord Mesenchymal Stem Cell
Sponsor:   PT. Prodia Stem Cell Indonesia
Recruiting
Posted: Wednesday, March 18, 2020 - 12:00
Angiographic Delivery of AD-MSC for Ulcerative Colitis
Condition:   Ulcerative Colitis
Intervention:   Drug: Adipose derived, autologous mesenchymal stem cells
Sponsor:   Mayo Clinic
Not yet recruiting
Posted: Tuesday, January 28, 2020 - 12:00
Combination of Autologous MSC and HSC Infusion in Patients With Decompensated Cirrhosis
Condition:   Cirrhosis, Liver
Interventions:   Combination Product: CD 34 and MSC infusion;   Drug: Standard of care for Cirrhosis management
Sponsor:   Asian Institute of Gastroenterology, India
Recruiting
Posted: Monday, December 9, 2019 - 12:00
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Condition:   Anal Fistula
Intervention:   Drug: E-CEL UVEC
Sponsors:   Weill Medical College of Cornell University;   Angiocrine Bioscience
Recruiting
Posted: Thursday, September 12, 2019 - 12:00
A Phase II Open-label Single-arm Study to Evaluate the Efficacy and Safety of Autologous Adipose-derived Stem Cells (ADSCs) in Subjects With Liver Cirrhosis
Condition:   Liver Cirrhosis
Intervention:   Drug: GXHPC1
Sponsor:   Gwo Xi Stem Cell Applied Technology Co., Ltd.
Not yet recruiting

Pages